Gene · 2192
FBLN1: fibulin 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FBLN1: fibulin 1. Genes, record 2192. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2192
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P23142 | Fibulin-1 | 703 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents30
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026515744 A | 2026-05-19 | 295 | P23142 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 46303 | P23142 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 5912 | P23142 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 858 | P23142 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 5635 | P23142 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 5128 | P23142 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6343 | P23142 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6343 | P23142 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 858 | P23142 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 5635 | P23142 | Espacenet |
1 to 10 of 30
See all 30 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,030
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FBLN1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 4 | 2025 |
| P30EY005722 | Center Core Grant for Vision Research | 4 | 2025 |
| P50CA097186 | The Pacific Northwest Prostate Cancer SPORE | 4 | 2025 |
| P20GM103499 | South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE) | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| T32GM008315 | Mechanisms of Trauma-Induced Coagulopathy | 3 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 1,030Source NIH's project files
See all 1,030 nih grantsPapers1,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FBLN1 Regulates Embryonic Myoblast Proliferation and Differentiation in Geese: Functional Characterization of a Meat Quality-Associated Candidate Gene From Prior Multi-Omics Screening. | Anim Genet | 2026 | 42806296 | PubTator, text mining | PubMed |
| Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes. | Res Pract Thromb Haemost | 2026 | 42787640 | PubTator, text mining | PubMed |
| Spatial compartmentalization of melanoma cell states reveals CAF-associated tumor cells with enhanced proliferative capacity. | PLoS One | 2026 | 42743160 | PubTator, text mining | PubMed |
| Single-cell transcriptomics deciphers cancer-associated fibroblast heterogeneity and immune regulatory mechanisms in the bladder cancer tumor microenvironment. | Front Cell Dev Biol | 2026 | 42729537 | PubTator, text mining | PubMed |
Integrative transcriptomic identification of potential common biomarkers between non-obstructive azoospermia and papillary thyroid cancer via multi-algorithmic machine learning and network biology approaches. | Cancer Treat Res Commun | 2026 | 42710154 | PubTator, text mining | PubMed |
| Fibulin-1 Improves Caerulein-Induced Acute Pancreatitis In Vitro by Inhibiting Ferroptosis. | J Biochem Mol Toxicol | 2026 | 42670805 | PubTator, text mining | PubMed |
| Immortalized smooth muscle cells enhance in vitro vasculogenesis. | Angiogenesis | 2026 | 42622755 | PubTator, text mining | PubMed |
| Impact of IL-5 Pathway Inhibition on Circulating Eosinophil- and Remodeling-Related Biomarkers in Severe Eosinophilic Asthma. | J Asthma Allergy | 2026 | 42609892 | PubTator, text mining | PubMed |
| Fibulin-1 is required for microvascular integrity in the developing brain and retina. | Dev Biol | 2026 | 42542239 | PubTator, text mining | PubMed |
| Identification of distinct gene and miRNA expression profiles in severe early-onset COPD providing novel insights in disease pathogenesis. | Thorax | 2026 | 42481400 | PubTator, text mining | PubMed |
1 to 10 of 1,552
See all 1,552 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2192
GET https://conductscience.org/api/genes/v1/2192/patents?page=2